The transcription factor JunD mediates transforming growth factor β-induced fibroblast activation and fibrosis in systemic sclerosis
K Palumbo, P Zerr, M Tomcik, S Vollath… - Annals of the …, 2011 - ard.bmj.com
K Palumbo, P Zerr, M Tomcik, S Vollath, C Dees, A Akhmetshina, J Avouac, M Yaniv…
Annals of the rheumatic diseases, 2011•ard.bmj.comObjectives Transforming growth factor β (TGFβ) has been identified as a key player in fibrotic
diseases. However, the molecular mechanisms by which TGFβ activates fibroblasts are
incompletely understood. Here, the role of JunD, a member of the activator protein 1 (AP-1)
family of transcription factors, as a downstream mediator of TGFβ signalling in systemic
sclerosis (SSc), was investigated. Methods The expression of JunD was analysed by real-
time PCR, immunofluorescence, western blotting and immunohistochemistry. The canonical …
diseases. However, the molecular mechanisms by which TGFβ activates fibroblasts are
incompletely understood. Here, the role of JunD, a member of the activator protein 1 (AP-1)
family of transcription factors, as a downstream mediator of TGFβ signalling in systemic
sclerosis (SSc), was investigated. Methods The expression of JunD was analysed by real-
time PCR, immunofluorescence, western blotting and immunohistochemistry. The canonical …
Objectives
Transforming growth factor β (TGFβ) has been identified as a key player in fibrotic diseases. However, the molecular mechanisms by which TGFβ activates fibroblasts are incompletely understood. Here, the role of JunD, a member of the activator protein 1 (AP-1) family of transcription factors, as a downstream mediator of TGFβ signalling in systemic sclerosis (SSc), was investigated.
Methods
The expression of JunD was analysed by real-time PCR, immunofluorescence, western blotting and immunohistochemistry. The canonical Smad pathway was specifically targeted by small interfering (si)RNA. The expression of extracellular matrix proteins in JunD deficient (JunD−/−) fibroblasts was analysed by real-time PCR and hydroxyproline assays. The mouse model of bleomycin-induced dermal fibrosis was used to assess the role of JunD in experimental fibrosis.
Results
JunD was overexpressed in SSc skin and in cultured fibroblasts in a TGFβ dependent manner. The expression of JunD colocalised with pSmad 3 in fibrotic skin and silencing of Smad 3 or Smad 4 by siRNA prevented the induction of JunD by TGFβ. JunD−/− fibroblasts were less responsive to TGFβ and released less collagen upon stimulation with TGFβ. Moreover, JunD−/− mice were protected from bleomycin-induced fibrosis with reduced dermal thickening, decreased myofibroblast counts and lower collagen content of lesional skin.
Conclusions
These data demonstrate that JunD is overexpressed in SSc and that JunD is a mediator of the profibrotic effects of TGFβ. Considering that inhibitors of AP-1 signalling have recently been developed and are available for clinical trials in SSc, these findings may have translational implications.
ard.bmj.com